News from cepheid A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jan 05, 2015, 08:00 ET Cepheid Announces CFO Change

Cepheid (Nasdaq: CPHD) today announced that Andrew Miller, executive vice president and chief financial officer, will be leaving Cepheid to pursue an ...


Dec 01, 2014, 07:00 ET Cepheid Receives FDA Clearance for Xpert Norovirus, the First On-Demand Molecular Test for Detection of Norovirus

Cepheid (NASDAQ: CPHD) today announced it has received clearance from the U.S. Food & Drug Administration (FDA) to market Xpert® Norovirus, a...


Nov 24, 2014, 04:05 ET Cepheid Receives FDA Clearance for Xpert Flu/RSV XC

Cepheid (NASDAQ: CPHD) today announced it has received clearance from the U.S. Food & Drug Administration (FDA) to market its Xpert® Flu/RSV XC, an...


Nov 20, 2014, 04:05 ET Cepheid to Webcast Upcoming Financial Presentations

Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate via...


Nov 13, 2014, 07:00 ET Cepheid To Develop Xpert Ebola For Countries Worst Hit By Epidemic

Cepheid (NASDAQ: CPHD) today announced that it has been awarded a grant of up to $3.3 million co-financed by the Paul G. Allen Family Foundation and...


Oct 16, 2014, 04:05 ET Cepheid Reports 2014 Third Quarter Results

Cepheid (Nasdaq: CPHD) today reported revenues for the third quarter of 2014 of $115.2 million, representing growth of 15% from $100.1 million for...


Oct 01, 2014, 04:05 ET Cepheid Extends Reach Of Direct US Commercial Operations

Cepheid (NASDAQ: CPHD) today announced that, effective today, it has entered into a purchase agreement to acquire the customer relationships from its ...


Oct 01, 2014, 04:04 ET Cepheid Schedules 2014 Third Quarter Results Announcement And Webcast

Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its 2014 third quarter ended September 30, 2014 on Thursday, October ...


Sep 04, 2014, 07:00 ET Cepheid Recognized as Innovation Leader

Cepheid (NASDAQ: CPHD) today announced that it has been named to Forbes magazine's list of the World's Most Innovative Growth Companies, reflecting...


Sep 03, 2014, 07:00 ET Cepheid Announces European Release of Xpert TV, a Next-Generation Molecular Test for Rapid and Accurate Identification of Trichomonas vaginalis Infections

Cepheid (NASDAQ: CPHD) today announced the release of Xpert® TV, an on-demand molecular test for rapid, accurate and reproducible identification of...


Sep 02, 2014, 07:00 ET Cepheid Announces European Release of Xpert Flu/RSV XC for Accurate and Reliable Detection and Differentiation of Flu A, Flu B, and RSV Infection

Cepheid (NASDAQ: CPHD) announced today the release of Xpert® Flu/RSV XC, an on-demand molecular test for rapid, accurate and reliable determination...


Jul 31, 2014, 04:05 ET Cepheid to Webcast Upcoming Financial Presentations

Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate via...


Jul 30, 2014, 04:05 ET Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement

Cepheid (Nasdaq: CPHD) today announced that its group purchasing contract with Premier will end on September 30, 2014. Customers currently purchasing ...


Jul 29, 2014, 07:00 ET Cepheid Reports China Installed Base Close To 1,000 GeneXpert® Systems

With the recent completion of a record shipment of 774 GeneXpert systems to a single country in one quarter, Cepheid (Nasdaq: CPHD) today applauded...


Jul 17, 2014, 04:05 ET Cepheid Reports 2014 Second Quarter Results

Cepheid (Nasdaq: CPHD) today reported revenues for the second quarter of 2014 of $116.5 million, representing growth of 21% from $96.0 million for...


Jul 03, 2014, 01:05 ET Cepheid Schedules 2014 Second Quarter Results Announcement And Webcast

Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its 2014 second quarter ended June 30, 2014 on Thursday, July 17,...


Jun 19, 2014, 07:00 ET Cepheid And Leading Pharmaceutical Companies Partner On A Diagnostic Test To Help Tackle Multidrug-Resistant Bacterial Infections

Cepheid (Nasdaq: CPHD) today announced a new collaboration with AstraZeneca, Cubist Pharmaceuticals, Inc., and GSK intended to promote...


Jun 16, 2014, 07:00 ET Cepheid Announces European Release of Xpert Carba-R, a Molecular Test for Rapid and Accurate Detection of Carbapenemase-producing Gram-negative Bacteria

Cepheid (NASDAQ: CPHD) today announced the release of Xpert® Carba-R, an on-demand molecular test for rapid and accurate detection of...


Jun 09, 2014, 04:05 ET Cepheid Welcomes Executive Vice President Of International Commercial Operations

Cepheid (Nasdaq: CPHD) today announced that it has appointed Mr. Peter Farrell to the position of Executive Vice President of International...


Apr 29, 2014, 04:05 ET Cepheid to Webcast Upcoming Financial Presentations

Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate via...


Apr 17, 2014, 04:05 ET Cepheid Reports 2014 First Quarter Results

Cepheid (Nasdaq: CPHD) today reported revenues for the first quarter of 2014 of $106.9 million, representing growth of 16% from $91.9 million for the ...


Apr 10, 2014, 07:00 ET Cepheid Announces European Release of Xpert Norovirus, the First On-Demand Molecular Test for Detection of Norovirus

Cepheid (NASDAQ: CPHD) today announced the release of Xpert® Norovirus, a qualitative in vitro diagnostic test for rapid identification and...


Apr 03, 2014, 04:05 ET Cepheid Schedules 2014 First Quarter Results Announcement and Webcast

Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its 2014 first quarter ended March 31, 2014 on Thursday, April 17,...


Mar 21, 2014, 07:00 ET In Recognition of World TB Day 2014, Cepheid and American Lung Association to Ring the NASDAQ Stock Market Opening Bell

Cepheid (Nasdaq: CPHD) today announced that James Post, Executive Vice President, North America Commercial Operations for Cepheid, and Harold P....


Mar 20, 2014, 07:00 ET Cepheid and American Lung Association to Reveal Winner of the 'Ride Against TB' Bike at 2nd Annual New York City TB Walk

Cepheid (Nasdaq: CPHD) today announced that the winner of the Ride Against TB bike, a prize in the campaign to benefit the American Lung Association, ...